Yüklüyor......
Asenapine: A Review of Acute and Extension Phase Data in Bipolar Disorder
The second generation atypical antipsychotic, asenapine (Saphris), was approved by the US FDA (August 2009) for the acute treatment of manic or mixed episodes with or without psychotic features associated with bipolar I disorder in adults as well as the acute treatment of schizophrenia. Asenapine ex...
Kaydedildi:
| Yayımlandı: | CNS Neurosci Ther |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Blackwell Publishing Ltd
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6493886/ https://ncbi.nlm.nih.gov/pubmed/20950326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2010.00200.x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|